Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Gil Ferreira

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Lung cancer in developing countries: access to molecular testingCarlos Gil Ferreira
Cancer|November 19, 2013
Reply to phase 1 study of cetuximab in combination with 5-fluorouracil, cisplatin, and radiotherapy in patients with locally advanced anal canal carcinomaLuis Olivatto, Carlos Gil Ferreira
The Oncologist|March 22, 2006
Making PubMed searching simple: learning to retrieve medical literature through interactive problem solvingBeatriz Vincent, Maurice Vincent, Carlos Gil Ferreira
Cancer Treatment Reviews|December 24, 2013
Antiangiogenesis beyond VEGF inhibition: a journey from antiangiogenic single-target to broad-spectrum agentsGabriel Limaverde-Sousa, Cinthya Sternberg, Carlos Gil Ferreira
Lung Cancer (Amsterdam, Netherlands)|May 31, 2016
Epidemiological changes in the histological subtypes of 35,018 non-small-cell lung cancer cases in BrazilGuilherme Costa, Luiz Claudio Santos Thuler, Carlos Gil Ferreira
Frontiers in Genetics|December 20, 2012
Bioinformatics of Cancer ncRNA in High Throughput Sequencing: Present State and ChallengesNatasha Andressa Nogueira Jorge, Carlos Gil Ferreira, Fabio Passetti
Molecular and Clinical Oncology|January 8, 2021
Dealing with lung cancer in the COVID-19 scenario (A review)Veronica Aran, Pedro De Marchi, Mauro Zamboni, et al.
Personalized Medicine|August 21, 2023
Challenges and opportunities in building a health economic framework for personalized medicine in oncologyPedro Nazareth Aguiar, Silvio Matsas, Rodrigo Dienstmann, et al.
Annals of Translational Medicine|January 8, 2019
Concurrent chemoradiotherapy for stage III non-small cell lung cancer: correct clinical management as the basis to move beyondGuilherme Jorge Costa, Carlos Gil Ferreira, Luiz Claudio Santos Thuler
Frontiers in Oncology|December 11, 2023
Editorial: Molecular genetic testing and emerging targeted therapies for non-small cell lung cancerCarlos Gil Ferreira, Marina Xavier Reis, Gilson Gabriel Viana Veloso
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Lung cancer in developing countries: access to molecular testingCarlos Gil Ferreira
Cancer|November 19, 2013
Reply to phase 1 study of cetuximab in combination with 5-fluorouracil, cisplatin, and radiotherapy in patients with locally advanced anal canal carcinomaLuis Olivatto, Carlos Gil Ferreira
The Oncologist|March 22, 2006
Making PubMed searching simple: learning to retrieve medical literature through interactive problem solvingBeatriz Vincent, Maurice Vincent, Carlos Gil Ferreira
Cancer Treatment Reviews|December 24, 2013
Antiangiogenesis beyond VEGF inhibition: a journey from antiangiogenic single-target to broad-spectrum agentsGabriel Limaverde-Sousa, Cinthya Sternberg, Carlos Gil Ferreira
Lung Cancer (Amsterdam, Netherlands)|May 31, 2016
Epidemiological changes in the histological subtypes of 35,018 non-small-cell lung cancer cases in BrazilGuilherme Costa, Luiz Claudio Santos Thuler, Carlos Gil Ferreira
Frontiers in Genetics|December 20, 2012
Bioinformatics of Cancer ncRNA in High Throughput Sequencing: Present State and ChallengesNatasha Andressa Nogueira Jorge, Carlos Gil Ferreira, Fabio Passetti
Molecular and Clinical Oncology|January 8, 2021
Dealing with lung cancer in the COVID-19 scenario (A review)Veronica Aran, Pedro De Marchi, Mauro Zamboni, et al.
Personalized Medicine|August 21, 2023
Challenges and opportunities in building a health economic framework for personalized medicine in oncologyPedro Nazareth Aguiar, Silvio Matsas, Rodrigo Dienstmann, et al.
Annals of Translational Medicine|January 8, 2019
Concurrent chemoradiotherapy for stage III non-small cell lung cancer: correct clinical management as the basis to move beyondGuilherme Jorge Costa, Carlos Gil Ferreira, Luiz Claudio Santos Thuler
Frontiers in Oncology|December 11, 2023
Editorial: Molecular genetic testing and emerging targeted therapies for non-small cell lung cancerCarlos Gil Ferreira, Marina Xavier Reis, Gilson Gabriel Viana Veloso
Pageof 9